Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R)

NCT00398463 Phase 4 COMPLETED

This study will evaluate whether adding tirofiban, administered at high bolus dose on top of aspirin and clopidogrel will lead to a lower rate of periprocedural myocardial infarction after percutaneous coronary intervention in elective patients presenting with aspirin and/or clopidogrel resistance.

Details

Lead sponsor	Università degli Studi di Ferrara
Phase	Phase 4
Status	COMPLETED
Enrolment	263
Start date	2006-05
Completion	2011-05

Conditions

• Angioplasty, Transluminal, Percutaneous Coronary

Interventions

• Tirofiban
• Placebo

Primary outcomes

• Troponin I or T elevation ratio at least three times the upper limit of normal. — 48 hours

Countries

Italy